Univec's bifurcated safety needle gains US nod:
This article was originally published in Clinica
Executive Summary
Univec has received FDA 510(k) clearance to market its bifurcated safety needle, which has been designed to meet the US government's requirements for safe administration of the smallpox vaccine. The Farmingdale, New York company says that its patented needles are the only bifurcated needles available that use a sliding sheath mechanism that complies with the US needle stick legislation and Occupational Safety and Health Administration (OSHA) regulations to effectively reduce the risk of accidental needle sticks.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.